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Conclusion: ICSI outcome and pregnancy results are compar-
able to those of IVF in patients with pure tubo-peritoneal
factor infertility.
to strict criteria were normal in all couples. All patients
had luteal-long gonadotrophin-releasing hormone analogue
protocol and standard procedures for ICSI and IVF. Chi-square
and independent t-tests were used for statistical analyses.
Results: These are given in Table I.
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Introduction: Embryo development and hatching are difficult
to observe as they take place inside an incubator and last
several days. Our goal was to develop a computerized video
capture system which allows the observation, recording and
analysis of these phenomena using fast-motion movies, while
keeping the embryo in an environment (temperature, light,
COb medium) suitable for its growth. Our first recordings
were aimed at comparing the development of control and zona
pellucida (ZP)-drilled mouse embryos.
Materials and methods: Zygotes are collected from female
mice and cultured for 1 day in carbonated human tubal fluid
medium supplemented with 5 mg/ml bovine serum albumin.
ZP microdrilling is performed with a single 30 ms shot using
a 1.48 urn diode laser system (Fertilase; Medical Technologies
Montreux, Switzerland), according to a technique described
elsewhere [Germond M. et ale (1995) Fertil. Steril., 64, 604-
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OHSS on the DET. Pts with ~12 oocytes and/or oestradiol
~2500 pg/ml were defined as high-risk-patients and separately
randomized to receive either protocols II or III. These groups
were defined as groups IV and V respectively. Complete data
of 241 pts were available at the time, when this abstract
was written.
Results: 50, 42, 42, 48, and 59 pts were randomized to
protocol I, II, III, IV, and V, respectively. Pregnancy rates (PR)
were 26.0, 19.0, 21.4, 27.1 and 28.8% in the five protocols.
Overall PR was 24.9%, PRs in the low-risk (I-III) and
high-risk groups (IV,V) were 22.4 and 28.0% respectively.
Implantation rates (IR) were 10.6, 11.9, 8.8, 13.7 and 11.3%
respectively. There was no significant difference between the
groups regarding PR or IR. Mean age was 31.84 ± 3.3,
34.04 ± 3.8, 33.52 ± 4.2, 31.02 ± 3.3, and 31.39 ± 4.0
years, respectively. There was a significant difference (Kruskal-
Wallis test, KWT) between group II versus groups IV and V,
as well as between groups III versus IV (P < 0.05). Body
mass index was not different between the groups. Mean
oestradiol was significantly higher in groups IV and V, com-
pared to groups I, II, and III (P < 0.05). The same held for
the number of oocytes retrieved (7.40 ± 2.6, 6.71 ± 3.2,
7.55 ± 2.9, 14.78 ± 5.2, 14.59 ± 5.3, in groups I, II, III,
IV, and V respectively). The cumulative embryo score was
significantly higher in group V (29.95 ± 8.3), compared to
group 11 (22.31 ± 11.7) and III (23.33 ± 10.5) (KWT, P <
0.05). Two severe OHSS were observed, one each in groups
IV and V. Three moderate OHSS occurred in the low-risk
group, all in group I, and one occurred in group V. Nineteen
mild OHSS were recorded, two in each of the low-risk groups,
six in group IV and seven in group V.
Conclusion: There is no indication to use HCG in LPS, since
there is no significant difference in PR between the groups.
There is a higher risk of OHSS after HCG administration. The
slight, non-significant differences observed between the PR
are mainly due to the differences in age and embryo quality,
which occurred despite a randomization system.
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Introduction: It is highly controversial whether intracyto-
plasmic sperm injection (ICSI) will replace standard in-vitro
fertilization (IVF) in patients with pure tubal factor infertility.
The aim of this prospective randomized study is to compare
ICSI versus IVF in women with tubo-peritoneal factor infer-
tility.
Materials and methods: Patients with tubo-peritoneal factor
infertility were randomized to ICSI (n = 38) or IVF (n = 38).
Semen analysis including morphology assessment according
Table I. Baseline characteristics and ICSIIIVF results.
ICSI-ET
Embryo transfer cycles (n) 38
Female age (years) 34 ± 3.96
Male age (years) 37.46 ± 4.15
Duration of infertility (years) 10.08 ± 4.19
Patients with unilbilateral hydrosalpinx (n) 4.0
Oestradiollevel-HCG (pmol/l) 5193.7 ± 3764
Oocytes (n) 9.08 ± 6.22
Metaphase-II oocytes (n) 7.32 ± 4.34
2-pronuclei rate (%) 69.03 ± 22.12
Cleavage rate (%) 66.87 ± 23.04
Embryos (n) 4.97 ± 3.06
Grade-I embryos (n) 3.45 ± 2.43
Embryos transferred (n) 3.39 ± 1.39
Grade-I embryos transferred (n) 2.71 ± 1.71
Individual implantation rate (%) 38.75 ± 24.46
Clinical pregnancy/ET(%) 21.05
Take-home babylET (%) 18.42
ET =. embryo transfer
All results are non-significant.
IVF-ET
38
34.03 ± 3.77
37.34 ± 4.75
9.06 ± 4.59
4.0
5071 ± 3060
8.11 ± 3.7
7.0 ± 3.5
67.32 ± 25.01
69.84 ± 23.73
5.0 ± 3.17
3.13 ± 2.54
3.61 ± 1.59
2.5 ± 1.43
34.58 ± 16.97
21.05
15.79
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611]. A single 2-cell embryo is transferred into aID ul culture
medium droplet under mineral oil inside a Petri dish, fitting
into an in-house constructed humidified micro-incubator, main-
tained at 37°C by water circulation and gassed with 5% CO2.
A CCD video camera mounted on the microscope sends a
signal to a frame grabber card located in a computer. The
image is digitized with a time lapse of several minutes and
stored as a file with a codified name generated automatically
by the computer software. Microscope light source and image
acquisition frequency are controlled by visual basic software
(PA Images, Swltzerland), which also generates the movies
from the stored image sequences.
Results: The specially designed micro-incubator offers an
environment compatible with embryo development. Normal
cleavage rates and hatching occur over the 4-5 days of culture
with only a need for medium renewal. In control embryos,
several extension/compaction movements (ECM) led to a
progressive thinning and to a sudden large slitting of the ZP
through which the expanded blastocyst quickly escapes. The
laser-drilled embryos start hatching 1 day earlier than the
controls by protruding through the drilled hole. The ECM do
not lead to ZP thinning and rupture; more ECM are needed
before hatching is completed.
Conclusion: We hereby present a new research tool which
allows us to study the hatching phenomenon as well as all the
other stages of the in-vitro development in embryos of all
species. The computerized images provide easily accessible
material for different measurements. The movies can be made
over longer periods of time than normal videos as they are
compiled to accelerate phenomena usually difficult to observe.
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Introduction: Thousands -of primordial follicles are present
in the ovaries of neonatal mammals. Until now, reproducible
conditions for a complete development of primordial follicles
in vitro have not been established. The aim of this study was
to achieve complete development of primordial follicles in
newborn mouse ovaries by combining in-vitro and in-vivo
steps. A two-step strategy was set-up. First the ovaries from
newborn mice were transplanted heterotopically under the
kidney capsule of ovariectomized adult female recipients; after
14 days, preantral follicles were isolated mechanically from
the recovered grafts and cultured in vitro for 12 days.
Materials and methods: Six- to eight-week-old F1 (C57BL/
6jXCBAlCa) female ovariectomized mice were used as recipi-
ents. Newborn F1 female mice (n = 6) were killed and
the ovaries were dissected free. Five ovaries that were not
transplanted were placed into Bouin's fluid and processed for
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histological examination. One newborn mouse ovary was
transplanted under the renal capsule of each recipient (n =
7). Two weeks after transplantation, preantral follicles were
isolated from four ovarian grafts and three recovered graft
ovaries were prepared for histological examination. The pre-
antral follicles were cultured individually in 20 ul a-MEM
medium supplemented with 100 mIU/ml recombinant follicular
stimulating hormone (rFSH) and 5% FCS in 60 mm petri
dishes incubated at a condition of 37°C, 100% humidity, and
5% CO2 in air for 12 days. Half of the medium was refreshed
every 2 days. At day 12 of culture, final oocyte maturation was
induced by adding 2.5 IU/ml human chorionic gonadotrophin
(HCG). The nuclear maturation of oocytes was assessed after
denudation from granulosa cells. Preantral follicles (n = 97)
isolated from 14-day-old mice were cultured under the same
conditions as control group. X2 test was used for statistical
analysis.
Results: All grafts (n = 7) were recovered 2 weeks after
transplantation. Histological examination of recovered grafts
(n = 3) revealed that follicles proceeded to preantral and
antral follicle stages with a predominance of preantral follicles.
Approximately 15:-25 preantral follicles were isolated mechan-
ically from each ovarian graft (n = 4) and total 64 selected
preantral follicles (100-150 urn in diameter) were put into
culture. There were differences between the control and the
transplanted groups in the percentage of follicle survival during
12 days in-vitro culture (98 versus 64% repectively; P <
0.0001), and in the percentage of oocytes that acquired
competence to undergo germinal vesicle breakdown (GVB)
(91 versus 65% respectively; P < 0.0001) or in the percentage
of GVB oocytes that produced a polar body, indicating progres-
sion of meiosis to metaphase 11 (86 versus 46% respectively;
P < 0.001).
Conclusion: The results reported here show that maturation of
mouse primordial follicles is possible by in-vivo transplantation
combined with in-vitro culture. This two-step method may be
a potentially attractive alternative to promote the transition
from primordial to preantral follicles that can be supported by
an in-vitro culture system.
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Introduction: Infertility in endometriosis patients has been
attributed to alterations within the oocyte which, in tum, result
in embryos of lower quality and reduced ability to implant.
The aim of this study was to compare the in-vitro fertilization
and embryo transfer (IVF/ET) outcome in oocyte recipients
with and without severe endometriosis receiving eggs from
the same donor.
